简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-08-01 14:15 Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
2024-08-01 14:10 Boston Oncology and King Fahd Medical City (KFMC) Partner to Advance Localized Cell & Gene Therapy in Saudi Arabia
2024-08-01 12:43 In-Depth Report on Global Oesophageal Cancer Clinical Trials Now Available
2024-08-01 11:51 Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program
2024-07-31 14:00 Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
2024-07-31 13:43 Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
2024-07-31 11:26 Carestream Wins Renowned Award for Dental Films
2024-07-31 09:57 JEOL : New Schottky Field Emission Scanning Electron Microscope JSM-IT810 Released
2024-07-30 13:06 Galderma’s Relfydess™ (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe
2024-07-30 11:28 Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease
2024-07-30 10:28 Myrobalan Therapeutics Names Grant Bogle to Board of Directors
2024-07-29 14:12 Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
2024-07-29 13:05 Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
2024-07-25 15:36 Kolmar BNH Expedites European Market Expansion with its Technology-Driven HemoHIM G
2024-07-25 15:30 Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round
2024-07-25 13:10 Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Currency for the First Half of 2024
2024-07-25 13:00 PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma’s Nemolizumab Improves Key Aspects of Atopic Dermatitis – Itch, Skin Lesions and Sleep Disturbance
2024-07-24 16:42 AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
2024-07-24 14:48 BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
2024-07-24 13:18 Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company

Business Wire Weibo

Press Releases

Latest Releases